Cargando…

A new scoring system for predicting survival in patients with non-small cell lung cancer

This analysis was performed to create a scoring system to estimate the survival of patients with non-small cell lung cancer (NSCLC). Data from 1274 NSCLC patients were analyzed to create and validate a scoring system. Univariate (UV) and multivariate (MV) Cox models were used to evaluate the prognos...

Descripción completa

Detalles Bibliográficos
Autores principales: Schild, Steven E, Tan, Angelina D, Wampfler, Jason A, Ross, Helen J, Yang, Ping, Sloan, Jeff A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567018/
https://www.ncbi.nlm.nih.gov/pubmed/26108458
http://dx.doi.org/10.1002/cam4.479
_version_ 1782389760842530816
author Schild, Steven E
Tan, Angelina D
Wampfler, Jason A
Ross, Helen J
Yang, Ping
Sloan, Jeff A
author_facet Schild, Steven E
Tan, Angelina D
Wampfler, Jason A
Ross, Helen J
Yang, Ping
Sloan, Jeff A
author_sort Schild, Steven E
collection PubMed
description This analysis was performed to create a scoring system to estimate the survival of patients with non-small cell lung cancer (NSCLC). Data from 1274 NSCLC patients were analyzed to create and validate a scoring system. Univariate (UV) and multivariate (MV) Cox models were used to evaluate the prognostic importance of each baseline factor. Prognostic factors that were significant on both UV and MV analyses were used to develop the score. These included quality of life, age, performance status, primary tumor diameter, nodal status, distant metastases, and smoking cessation. The score for each factor was determined by dividing the 5-year survival rate (%) by 10 and summing these scores to form a total score. MV models and the score were validated using bootstrapping with 1000 iterations from the original samples. The score for each prognostic factor ranged from 1 to 7 points with higher scores reflective of better survival. Total scores (sum of the scores from each independent prognostic factor) of 32–37 correlated with a 5-year survival of 8.3% (95% CI = 0–17.1%), 38–43 correlated with a 5-year survival of 20% (95% CI = 13–27%), 44–47 correlated with a 5-year survival of 48.3% (95% CI = 41.5–55.2%), 48–49 correlated to a 5-year survival of 72.1% (95% CI = 65.6–78.6%), and 50–52 correlated to a 5-year survival of 84.7% (95% CI = 79.6–89.8%). The bootstrap method confirmed the reliability of the score. Prognostic factors significantly associated with survival on both UV and MV analyses were used to construct a valid scoring system that can be used to predict survival of NSCLC patients. Optimally, this score could be used when counseling patients, and designing future trials.
format Online
Article
Text
id pubmed-4567018
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher John Wiley & Sons, Ltd
record_format MEDLINE/PubMed
spelling pubmed-45670182015-09-17 A new scoring system for predicting survival in patients with non-small cell lung cancer Schild, Steven E Tan, Angelina D Wampfler, Jason A Ross, Helen J Yang, Ping Sloan, Jeff A Cancer Med Clinical Cancer Research This analysis was performed to create a scoring system to estimate the survival of patients with non-small cell lung cancer (NSCLC). Data from 1274 NSCLC patients were analyzed to create and validate a scoring system. Univariate (UV) and multivariate (MV) Cox models were used to evaluate the prognostic importance of each baseline factor. Prognostic factors that were significant on both UV and MV analyses were used to develop the score. These included quality of life, age, performance status, primary tumor diameter, nodal status, distant metastases, and smoking cessation. The score for each factor was determined by dividing the 5-year survival rate (%) by 10 and summing these scores to form a total score. MV models and the score were validated using bootstrapping with 1000 iterations from the original samples. The score for each prognostic factor ranged from 1 to 7 points with higher scores reflective of better survival. Total scores (sum of the scores from each independent prognostic factor) of 32–37 correlated with a 5-year survival of 8.3% (95% CI = 0–17.1%), 38–43 correlated with a 5-year survival of 20% (95% CI = 13–27%), 44–47 correlated with a 5-year survival of 48.3% (95% CI = 41.5–55.2%), 48–49 correlated to a 5-year survival of 72.1% (95% CI = 65.6–78.6%), and 50–52 correlated to a 5-year survival of 84.7% (95% CI = 79.6–89.8%). The bootstrap method confirmed the reliability of the score. Prognostic factors significantly associated with survival on both UV and MV analyses were used to construct a valid scoring system that can be used to predict survival of NSCLC patients. Optimally, this score could be used when counseling patients, and designing future trials. John Wiley & Sons, Ltd 2015-09 2015-06-23 /pmc/articles/PMC4567018/ /pubmed/26108458 http://dx.doi.org/10.1002/cam4.479 Text en © 2015 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. http://creativecommons.org/licenses/by/4.0/ This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Cancer Research
Schild, Steven E
Tan, Angelina D
Wampfler, Jason A
Ross, Helen J
Yang, Ping
Sloan, Jeff A
A new scoring system for predicting survival in patients with non-small cell lung cancer
title A new scoring system for predicting survival in patients with non-small cell lung cancer
title_full A new scoring system for predicting survival in patients with non-small cell lung cancer
title_fullStr A new scoring system for predicting survival in patients with non-small cell lung cancer
title_full_unstemmed A new scoring system for predicting survival in patients with non-small cell lung cancer
title_short A new scoring system for predicting survival in patients with non-small cell lung cancer
title_sort new scoring system for predicting survival in patients with non-small cell lung cancer
topic Clinical Cancer Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567018/
https://www.ncbi.nlm.nih.gov/pubmed/26108458
http://dx.doi.org/10.1002/cam4.479
work_keys_str_mv AT schildstevene anewscoringsystemforpredictingsurvivalinpatientswithnonsmallcelllungcancer
AT tanangelinad anewscoringsystemforpredictingsurvivalinpatientswithnonsmallcelllungcancer
AT wampflerjasona anewscoringsystemforpredictingsurvivalinpatientswithnonsmallcelllungcancer
AT rosshelenj anewscoringsystemforpredictingsurvivalinpatientswithnonsmallcelllungcancer
AT yangping anewscoringsystemforpredictingsurvivalinpatientswithnonsmallcelllungcancer
AT sloanjeffa anewscoringsystemforpredictingsurvivalinpatientswithnonsmallcelllungcancer
AT schildstevene newscoringsystemforpredictingsurvivalinpatientswithnonsmallcelllungcancer
AT tanangelinad newscoringsystemforpredictingsurvivalinpatientswithnonsmallcelllungcancer
AT wampflerjasona newscoringsystemforpredictingsurvivalinpatientswithnonsmallcelllungcancer
AT rosshelenj newscoringsystemforpredictingsurvivalinpatientswithnonsmallcelllungcancer
AT yangping newscoringsystemforpredictingsurvivalinpatientswithnonsmallcelllungcancer
AT sloanjeffa newscoringsystemforpredictingsurvivalinpatientswithnonsmallcelllungcancer